Kusajili – Clinical trials directory

Result of your search per sponsor: Institute of Diabetes “Gerhardt Katsch”

Woman and Man Max 99 years
Institute of Diabetes “Gerhardt Katsch” Update Il y a 4 ans

Prediction of the efficacy of exenatide treatment in suboptimally controlled type 2 diabetic patients by “Metabolic Fingerprint” and evidence-based KADIS® decision support: a clinical pilot trial to assess the predictive power of in-silico evaluation of glycemic control with exenatide and insulin glargine

Country None
organs None
Specialty None

Closed trial

More information